相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Update in Pulmonary Hypertension 2008
Marc Humbert
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia
L. B. Smoot et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2009)
Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2009)
Hereditary haemorrhagic telangiectasia: a clinical and scientific review
Fatima S. Govani et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
The pulmonary vascular complications of hereditary haemorrhagic telangiectasia
M. E. Faughnan et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Guidelines for the diagnosis and treatment of pulmonary hypertension
N. Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Genetics and Genomics of Pulmonary Arterial Hypertension
Rajiv D. Machado et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Updated Clinical Classification of Pulmonary Hypertension
Gerald Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre
D. Montani et al.
EUROPEAN RESPIRATORY REVIEW (2009)
Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasis and severe PAH
D. Montani et al.
EUROPEAN RESPIRATORY REVIEW (2009)
Pulmonary hypertension
Gorev Grubu Uyeleri et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2009)
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation
Benjamin Sztrymf et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension
Maya Fujiwara et al.
CIRCULATION JOURNAL (2008)
Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension
Erika B. Rosenzweig et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2008)
Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia
C. L. Shovlin et al.
THORAX (2008)
Extracellular control of TGFβ signalling in vascular development and disease
Peter ten Dijke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Characterization of the BMPR2 5′-untranslated region and a novel mutation in pulmonary hypertension
Micheala A. Aldred et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells
Laurent David et al.
BLOOD (2007)
Genes and pulmonary arterial hypertension
Benjamin Sztrymf et al.
RESPIRATION (2007)
High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension
Joy D. Cogan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension
C. Gregory Elliott et al.
CIRCULATION (2006)
Pulmonary arterial hypertension in France - Results from a national registry
M Humbert et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5
SG Cole et al.
JOURNAL OF MEDICAL GENETICS (2005)
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension
O Sitbon et al.
CIRCULATION (2005)
Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension
RD Machado et al.
CIRCULATION (2005)
Transforming growth factor-β receptor mutations and pulmonary arterial hypertension in childhood
RE Harrison et al.
CIRCULATION (2005)
Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia
V Cottin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension
A Chaouat et al.
THORAX (2004)
A combined syndrome of juvenile polyposis and hereditary haemorrhagic telanglectasia associated with mutations in MADH4 (SMAD4)
CJ Gallione et al.
LANCET (2004)
Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia
SA Abdalla et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Drug therapy: Treatment of pulmonary arterial hypertension
M Humbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Screening, early detection, and diagnosis of pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines
M McGoon et al.
CHEST (2004)
Cellular and molecular pathobiology of pulmonary arterial hypertension
M Humbert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Clinical classification of pulmonary hypertension
G Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia
RE Harrison et al.
JOURNAL OF MEDICAL GENETICS (2003)
Hereditary haemorrhagic telangiectasia (Osier-Weber-Rendu syndrome): a view from the 21st century
ME Begbie et al.
POSTGRADUATE MEDICAL JOURNAL (2003)
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension -: Prognostic factors and survival
O Sitbon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
RC Trembath et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
